What is the difference between HIV treatments Genvoya and Stribild?
Medically reviewed by Drugs.com Last updated on Oct 7, 2019.
Official Answer
by Drugs.comGenvoya and Stribild are both four-drug, antiviral combinations containing elvitegravir, cobicistat, emtricitabine, and tenofovir indicated as complete regimens for the treatment of HIV-1 infection. The difference between Genvoya and Stribild is in the form of tenofovir contained in each product. Genvoya contains a newer form of tenofovir called tenofovir alafenamide (TAF) and Stribild contains the original form of tenofovir as tenofovir disoproxil fumarate (TDF).
Tenofovir alafenamide is a prodrug of tenofovir that has been designed to enter HIV-infected cells more efficiently than TDF, and it can therefore be given at a much lower dose (less than one-tenth) than TDF. TAF appears to be associated with less kidney toxicity and decreases in bone density compared to TDF.
The dose for both Genvoya and Stribild is one tablet taken orally once daily with food.
| Genvoya | Stribild | |
|---|---|---|
| FDA Approved | November 5, 2015 | August 27, 2012 |
| How Supplied |
Each tablet contains:
|
Each tablet contains:
|
| Indication |
HIV-1 Infection
|
HIV-1 Infection
|
Genvoya and Stribild are both manufactured by Gilead Sciences Inc.
Related Medical Questions
- What is Genvoya used to treat?
- Why do you take Genvoya with food?
- Does Genvoya make you gain weight?
- What is the difference between HIV treatments Odefsey and Complera?
- What drugs are contained in the HIV treatment Symfi Lo?
- How much does HIV treatment Cimduo cost?
- What drugs are contained in the HIV treatment Cimduo?
